A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Wayne Hooper Clinic Clive Berghofer Cancer Research Center
Herston, Queenland, Australia
- Mater Hospital
South Brisbane, Queensland, Australia
- Linear Clinical Research
Perth, Western Australia, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jun 2017
- Primary completion
- 31 May 2018
- Completion
- 31 May 2018
- Last update posted
- 6 Sept 2018
- Registered enrollment
- 109
- Registry id
- NCT03173573
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.